Answers are grounded in this paper and cite their sources.
Evaluate the safety and tolerability of QRL-201 in people living with amyotrophic lateral sclerosis.
No takes yet. Share an insight, caveat, or question.
Genge et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: